Background: The influence of gastric Helicobacter pylori infection on the development of oral pathoses remains unclear. The aim of this study is to examine the influence of gastric H. pylori infection on occurrence of halitosis and coated tongue.
INTRODUCTION
Helicobacter pylori is a microaerophylic, Gram-negative bacterium which primary ecological niche is the human stomach. H. pylori infection is one of the most common chronic bacterial infections worldwide, with more than half of the world's population in both developed and developing countries being infected with this organism. 4 While infection is thought to be acquired in early childhood in most cases, epidemiological studies have also suggested new infections can be acquired during adulthood. Reported annual incidence rates vary significantly and range from 0 to 35%. 8 The pathogenic properties of H. pylori include its ability to survive in the gastric juice, to escape the gastric acidity and to colonise the gastric mucosa. Infection with the organism is strongly associated with dyspeptic diseases (oesophagitis, peptic and duodenal ulcers, gastritis, duodenitis) and gastric cancer. 5 Current eradication regimen comprises of proton pump inhibitors and combination of antibiotics. Elimination of the infection greatly reduces the risk of disease relapse but in some cases the organism is not completely eliminated at the first attempt and the recurrence of infection is well-documented. 17 In addition to the involvement in the local pathosis, H. pylori has been implicated in the pathogenesis of some extragastric diseases, such as idiopathic thrombocytopenic purpura, iron deficiency anemia, chronic idiopathic urticaria and hepatocellular carcinoma. There is also an increasing evidence for a possible association of H. pylori with cardiovascular diseases. 15 Pathophysiological mechanisms responsible for development of extragastic diseases include gastrointestinal blood loss and insufficient dietary iron absorption as well as autoimmune mechanisms. 9 Halitosis and coated tongue are multifactorial oral conditions that can cause deep psychological stress to long time sufferers. A possible link between H. pylori and breath odor was first suggested in 1993 and several later clinical studies reported close relationship between H. pylori infection, halitosis and glossitis. 1 In addition, H. pylori has been shown to produce hydrogen sulphide and methyl mercaptan, implying that this microorganism could contribute to the development of halitosis. 7 The tongue coating has been shown to be a major source of volatile sulfur compounds production. 20 More than 700 bacterial species inhabit the oral cavity and the tongue coating, in particular, provides a reservoir for oral micro-organisms. Association between changes in tongue coating and gastric H. pylori infection has been indicated in various studies. The aim of our study was to examine the association between gastric H. pylori infection, the presence of the bacterium in saliva, halitosis and coated tongue and the influence of systemic eradication therapy on these oral pathosis.
MATERIALS AND METHODS

Subjects and Sampling
In this double-blind, case-control interventional clinical study, 98 subjects with dyspepsia (42 male and 56 female, age range from 19 to 78 years) were examined. All participants signed the consent form, before undergoing research procedures, agreeing to their participation in the clinical protocol. The study was approved by the Ethical Committee of the School of Dentistry, University of Belgrade. Exclusion criteria were the use of antimicrobials and Proton Pump Inhibitors within the 3 months before the study, previous eradication therapy and hypersensitivity to amoxicillin or clarithromycin.
Two investigators assessed the presence of halitosis and the tongue coating index independently. All participants received a letter with instructions. Two days before their appointment, they had to avoid garlic, onions, and spicy food in their diet. Twelve hours before the measurements, they also had to refrain from alcohol or coffee. On the morning of the appointment, they were forbidden to use chewing gums, mints, drops, scents, and mouth rinses. In contrast, they could perform normal oral hygiene (tooth brushing) and have breakfast. All measurements were recorded between 9:00 am and 12:00 pm. The organoleptic halitosis score was determined at the distance of 10 cm by two trained judges who tested their ability to distinguish odors using the Smell Identification Test (Sensonics Inc, Haddon Heights, NJ, USA). Patients were instructed not to speak for several minutes prior to the examination. Organoleptic malodor scores 14 were recorded independently by each judge on a scale from 0 to 4 as follows: 0-no appreciable odor; 1 -slight oral malodor; 2-moderate oral malodor; 3-strong oral malodor and 4-very strong oral malodor. Patients were considered positive for halitosis if both examiners scored them 2 or higher.
Tongue coating index (TCI) was assessed by visual method based on observation of thickness of tongue coating as describe by Shimizu et al. 16 Score 0: Tongue coating not visible. Score 1: Tongue coating thin, papillae of tongue visible.
Score 2: Tongue coating very thick, papillae of tongue not visible.
Participants were regarded as to having coated tongue if both examiners gave score 1 or higher. In addition, unstimulated saliva was collected in a sterile tube during 1 minute for H. pylori detection.
Subsequent to oral cavity inspection, all patients underwent upper esophagogastroduodenoscopy with biopsy, performed with GIF 165L endoscope, Olympus Co Tokyo, Japan. Two samples from the same patient were taken of the greater and lesser curvature of the gastric antrum up to 5 cm from the pylorus, and of lesion if any, and stored in a sterile tube containing 0.5 ml of Tris EDTA buffer, at -20ºC until PCR analyses.
DNA Extraction and PCR Amplification
Whole DNA was extracted from saliva and gastric samples by the boiling method followed by Nested-PCR using species-specific primers for H. pylori. DNA from a reference strain ATCC 43629 H. pylori was used as a positive control. Following DNA extraction, 2 μl of DNA were used for PCR. The amplification was performed in a 25 μl mixture containing Taq DNA polymerase (1 unit/ reaction), PCR buffer (50 mM KCl, 10 mM Tris-HCl pH 7.4 and 1.5 mM MgCl 2 ), deoxynucleoside triphosphates (0.1mM/reaction of each dNTP) and primers (20 pmol each/reaction). All samples were amplified using a DNA thermal cycler (PCR Express, HYBAID Corp, USA). The cycling conditions were: initial denaturation at 94ºC for 3 minutes and 35 cycles of: 94ºC (1 minute), 57ºC (1 minute), JCDP 72ºC (1 minute) and a final extension step at 72ºC for 5 minutes. The first round of amplification was performed with the following primer pair (Applied Biosystems, UK) designated as outer primers:
5'-CAGTTATTTGGTGGCTACAACCG-3'and 5'-CCCATCAATAGACGCTTAATCC-3' The expected PCR product size was 956 bp. After the first round of PCR, 2 μl of the final product were transferred to a fresh tube and reamplified using the same program and conditions as previously indicated, but with a primer pair designated as inner primers:
5'-GCTGTAATTTAAGGGTGGGGGTTG-3' and 5'-TGCCGTAATTCAACTGCAAGCG-3' with an expected PCR product of 345 bp.
Polyacrylamide Gel Electrophoresis
Ten microliter of final PCR products were mixed with 2 μl of gel loading dye (0.25% bromophenol blue, 30% glycerol and 10 mM Tris EDTA, pH 7.6), loaded into 8% polyacrylamide gel and electrophoresed using 1 × TEA buffer. DNA fragments were visualized after staining with ethidium bromide using a BIO-RAD GEL-DOC 1000 detection system.
Study Design
Following the assessment of gastric H. pylori infection by Nested-PCR, 66 subjects positive for gastric infection were given the triple eradication therapy which consisted of Amoxicillin 2 g/day (g/d), Clarithromycin 1 g/d and Pantoprazole 80 mg/d, for 7 days. Three months after the completion of the eradication therapy all 66 participants underwent control examination with oral and endoscopic evaluation, taking samples as at the beginning of the study.
Statistical Analysis
The occurrence of halitosis and coated tongue was compared between the patients with gastric H. pylori infection and those without detected bacterium in their biopsy samples, both before and after the eradication therapy. Comparisons were performed using a two-tails Fisher's test. The significance was set at p-value of < 0.05.
RESULTS
At initial examination H. pylori was detected in gastric samples of 66 out of 98 examined subjects with dyspepsia, using Nested-PCR method. Only one saliva sample was positive for H. pylori. Halitosis was observed in 20 patients (30.3%) who had gastric infection and in only 3 patients (9.4%) out of 32 without H. pylori infection (p = 0.0236). Coated tongue was diagnosed in 18 (27.2%) patients with the infection compared to only 2 (6.25%) patients negative for gastric H. pylori (p = 0.0164) ( Table 1) .
Three months after the completion of the eradication therapy 47 (71%) patients out of originally 66 infected were negative for gastric H. pylori while 19 (29%) of them still harbored the bacterium in their stomach. All of the saliva samples were now negative for H. pylori. Halitosis was observed in 8 (42.1%) subjects with persistent gastric infection and in only 3 subjects (6.4%) from the group where infection was successfully eradicated (p = 0.0012). Coated tongue was diagnosed in 9 patients (47.4%) where H. pylori was still present in gastric biopsies and in only 3 patients (6.4%) where eradication therapy succeeded (p = 0.0003) ( Table 2) .
DISCUSSION
There is a strong correlation between H. pylori infection with gastritis, gastric and duodenal ulcer and the development of gastric cancer. 11 However, the association between gastric H. pylori infection and oral pathology is still controversial. Some studies have indicated possible involvement of H. pylori in the pathogenesis of glossitis, halitosis, burning mouth syndrome, recurrent aphthous ulcerations and even periodontitis. 13 Detection of H.
pylori in oral samples varies significantly, ranging from 0 to 100%. 19 Studies evaluating prevalence of H. pylori in the oral cavity showed conflicting data and influence of the local infection on oral pathology is not clear. 12 The number of H. pylori detected in oral samples is usually very small and its presence may be only transient resulting from gastric reflux, a symptom common in gastroesophageal diseases. 2 Moreover, even if it is present in the mouth, systemic eradication therapy has been shown to have 100% eradication rate for oral H. pylori Our results indicate association between gastric H. pylori infection, halitosis and coated tongue and show for the first time that these two oral conditions are significantly improved after successful gastric eradication of this bacterium. At initial examination, about one third of infected patients suffered from halitosis and coated tongue, compared to only less than 10% of patients with dyspeptic diseases but without gastric H. pylori infection. Three months after completion of applied triple therapy, H. pylori was eradicated in 71.2% of patients. Half of the patients where eradication therapy failed and who had a recurrence of infection, still suffered from coated tongue and halitosis, while in the group where H. pylori was successfully eradicated the prevalence of halitosis and coated tongue was significantly lower (6%).
Several other studies have found a higher rate of halitosis among H. pylori positive patients with dyspeptic diseases than in those who were H. pylori negative. 18 Hoshi et al reported that levels of hydrogen-sulfide and dimethyl-sulfide in mouth air were significantly higher in H. pylori positive then in H. pylori negative patients. 7 In addition, gastric H. pylori infection has also been associated with lingual hyperplasia, burning mouth syndrome and atrophic glossitis. 22 In this interventional study, we showed for the first time that successful eradication of gastric H. pylori ameliorated halitosis and coated tongue.
CONCLUSION
Our findings implicate clear association between gastric H. pylori infection and occurrence of halitosis and coated tongue. Eradication of gastric H. pylori infection significantly improves these two very common oral conditions.
CLINICAL SIGNIFICANCE
In the absence of local factors, patients with persistent halitosis and coated tongue should be referred to and treated by gastroenterologists.
